Kinder Morgan Aktie News

Clearway Energy anticipates growing its cash flow per share by 7% to 8% annually through 2030. Kinder Morgan has lined up $9.3 billion of expansion projects that it expects to complete by 2030.

Kinder Morgan is positioned as a critical energy infrastructure provider, benefiting from surging demand driven by AI-powered data centers and rising electricity needs. KMI's Q3 results showed strong growth in revenue, adjusted EBITDA, and cash flow, underpinned by increased natural gas volumes and a robust $9.3 billion project backlog. KMI's fee-based business model, expanding infrastructure, ...

I share the one chart that is not getting nearly enough attention, given its immense implications for the world economy. This chart reveals a massive power shift that markets haven't priced in, and it could reshape the entire future of AI, manufacturing, and geopolitics. I detail how I am positioning my portfolio to take advantage of it.

Energy sector fundamentals are strengthening as both demand and supply are increasingly supported by governments and major organizations, reversing years of pessimism. Oil and natural gas demand is projected to grow through 2050, with the IEA and Goldman Sachs revising their outlooks upward, especially as renewables adoption slows. Midstream companies like WMB, KMI, TRP, ET, DT, and MPLX are po...

Discover the 3 dividend-paying powerhouses I'd trust to fund a lifetime of passive income. These high-yield investments combine safety, growth, and tax efficiency like few others. Learn why I believe these picks could anchor a durable dividend retirement portfolio.

Kinder Morgan is on track to grow even faster than anticipated this year. It has secured several new expansion projects, further enhancing its long-term growth profile.

Liquid natural gas (LNG) exports to Europe and Asia, combined with the increasing electricity demand from data centers, are expected to significantly increase natural gas consumption in the U.S.

In the past week or so, beneficial owners took advantage of MapLight Therapeutics Inc.